Literature DB >> 27764243

Correction: Identification of Novel Pre-Erythrocytic Malaria Antigen Candidates for Combination Vaccines with Circumsporozoite Protein.

C Speake, A Pichugin, T Sahu, V Malkov, R Morrison, Y Pei, L Juompan, N Milman, S Zarling, C Anderson, N J MacDonald, S Wong-Madden, J Wendler, A Ishizuka, Z W MacMillen, V Garcia, S H Kappe, U Krzych, P E Duffy.   

Abstract

[This corrects the article DOI: 10.1371/journal.pone.0159449.].

Entities:  

Year:  2016        PMID: 27764243      PMCID: PMC5072645          DOI: 10.1371/journal.pone.0165489

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


Dr. Nicholas J. MacDonald should be included in the author byline. Dr. MacDonald should be listed as the eleventh author, and with the affiliation 3: Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America. The contributions of this author are as follows: Conception and design of the work, acquisition of data, or analysis and interpretation of data; drafting the article or revising it critically for important intellectual content; final approval of the version to be published; agreement to be accountable for all aspects of work; conceptualization; methodology; investigation; and resources.
  1 in total

1.  Identification of Novel Pre-Erythrocytic Malaria Antigen Candidates for Combination Vaccines with Circumsporozoite Protein.

Authors:  Cate Speake; Alexander Pichugin; Tejram Sahu; Vlad Malkov; Robert Morrison; Ying Pei; Laure Juompan; Neta Milman; Stasya Zarling; Charles Anderson; Sharon Wong-Madden; Jason Wendler; Andrew Ishizuka; Zachary W MacMillen; Valentino Garcia; Stefan H I Kappe; Urszula Krzych; Patrick E Duffy
Journal:  PLoS One       Date:  2016-07-19       Impact factor: 3.240

  1 in total
  1 in total

Review 1.  Current Challenges in the Identification of Pre-Erythrocytic Malaria Vaccine Candidate Antigens.

Authors:  Paulo Bettencourt
Journal:  Front Immunol       Date:  2020-02-21       Impact factor: 7.561

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.